ResMed | RMD - Trade Creditors


ResMed reported $320.68M in Trade Creditors for its fiscal quarter ending in September of 2026.





Trade Creditors Change Date
Ansell USD 302.3M 51.4M Dec/2025
Artivion USD 17.63M 3.24M Sep/2026
AtriCure USD 80.24M 1.5M Sep/2026
Baxter International USD 1.02B 10M Sep/2026
Cochlear AUD 281.3M 17.1M Dec/2025
Cooper Companies USD 251.2M 17.9M Jun/2026
CSL USD 3.17B 290M Dec/2025
Dexcom USD 2.08B 134.8M Jun/2026
Edwards Lifesciences USD 199.7M 10.8M Sep/2026
Fisher Paykel Healthcare NZD 300.1M 32.3M Jun/2026
Globus Medical USD 107.43M 487K Sep/2026
Haemonetics USD 71.64M 15.3M Sep/2026
Idexx Laboratories USD 154.09M 24.99M Sep/2026
Inogen USD 21.22M 684K Sep/2025
Insulet USD 162.2M 38.9M Sep/2026
Integra LifeSciences USD 82.64M 5.31M Jun/2026
Intuitive Surgical USD 2.56B 645M Sep/2026
Medtronic USD 2.7B 51M Jun/2026
Philips EUR 2.14B 56M Sep/2026
Ramsay Health Care AUD 2.02B 289.9M Dec/2025
ResMed USD 320.68M 11.75M Sep/2026
Sigma Healthcare AUD 1.32B 970.03M Dec/2025
Sonic Healthcare AUD 313.54M 543.93M Jun/2024
Steris USD 334.2M 9.9M Sep/2026
Teleflex USD 142.87M 423K Sep/2026
Thermo Fisher Scientific USD 3.09B 181M Sep/2026